Compare BMA & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMA | INDV |
|---|---|---|
| Founded | 1966 | N/A |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 2006 | 2014 |
| Metric | BMA | INDV |
|---|---|---|
| Price | $81.95 | $31.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $96.75 | N/A |
| AVG Volume (30 Days) | 279.6K | ★ 1.9M |
| Earning Date | 05-27-2026 | 06-08-2026 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $16.25 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $33.22 | ★ $19.23 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $38.30 | $8.69 |
| 52 Week High | $106.15 | $38.00 |
| Indicator | BMA | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 60.76 | 53.21 |
| Support Level | $64.88 | $31.70 |
| Resistance Level | $94.54 | $32.42 |
| Average True Range (ATR) | 3.37 | 1.20 |
| MACD | 1.12 | 0.29 |
| Stochastic Oscillator | 90.25 | 67.54 |
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).